Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Headline outcomes only

No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 2 · 50%

Overall local/injection site adverse events · 9‐ to 14‐year‐old females and males

The review found no eligible studies for this question.

1 finding from 1 review

Overall local/injection site adverse events · 9‐ to 15‐year‐old females

The review found no eligible studies for this question.

1 finding from 1 review

Overall local/injection site adverse events at 15‐day · 10‐ to 26‐year‐old males

Three doses HPV vaccine leads to higher overall local/injection site adverse events at 15‐day compared with control (high certainty).

1 finding from 1 review

Overall local/injection site adverse events at 15‐day · 9‐ to 26‐year‐old females and males

Nonavalent HPV vaccine leads to higher overall local/injection site adverse events at 15‐day compared with quadrivalent HPV vaccine (high certainty).

1 finding from 1 review